NuCana (NCNA) EPS (Basic) (2017 - 2025)

NuCana (NCNA) reported EPS (Basic) of -$0.0 for Q4 2025, down 480.58% on a YoY basis from $0.0 in Q4 2024, and down 1498.67% sequentially from -$0.0 in Q3 2025.

NuCana (NCNA) EPS (Basic) (2017 - 2025) Analysis & Trends

NuCana (NCNA) has 9 years of EPS (Basic) data on file, last reported at -$0.0 in Q4 2025.

  • For the quarter ending Q4 2025, EPS (Basic) fell 480.58% year-over-year to -$0.0; the trailing twelve-month figure through Dec 2025 stood at -$0.0 (down 114.78% YoY), and the FY2025 full-year result was -$0.0, down 127.31% from the prior year.
  • EPS (Basic) slipped to -$0.0 in Q4 2025, from -$0.0 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.03 in Q2 2021 to a low of -$0.04 in Q4 2021.
  • A 5-year average of -$0.01 and a median of -$0.0 in 2023 frame the typical range for EPS (Basic).
  • Across the five-year window, EPS (Basic) soared 205.69% in 2021 and plunged 698.09% in 2025, its largest moves.
  • Tracing NCNA's EPS (Basic) over 5 years: stood at -$0.04 in 2021, then advanced by 3.43% to -$0.04 in 2022, then jumped by 47.05% to -$0.02 in 2023, then soared by 99.75% to -$0.0 in 2024, then plunged by 480.58% to -$0.0 in 2025.
  • Business Quant data shows NCNA's EPS (Basic) at -$0.0 in Q4 2025, -$0.0 in Q3 2025, and -$0.01 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 0.00
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 0.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 0.16
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 4.06
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 6.99
7 Belite Bio 61.40 Bn 61.40 Bn - 0.00
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 5.90
9 Revolution Medicines 37.37 Bn 37.37 Bn - -2.29
10 NuCana 14.60 Bn 14.60 Bn - 0.00

Historic Data

Download Data
DateValue
Dec 31, 2025 0.00
Sep 30, 2025 0.00
Jun 30, 2025 -0.01
Mar 31, 2025 0.00
Dec 31, 2024 0.00
Sep 30, 2024 0.00
Jun 30, 2024 0.00
Mar 31, 2024 0.00
Dec 31, 2023 -0.02
Sep 30, 2023 0.00
Jun 30, 2023 0.00
Mar 31, 2023 -0.02
Dec 31, 2022 -0.04
Sep 30, 2022 -0.01
Jun 30, 2022 0.01
Mar 31, 2022 -0.03
Dec 31, 2021 -0.04
Sep 30, 2021 -0.03
Jun 30, 2021 0.03
Mar 31, 2021 -0.03